UC studies tobacco use, cancer connection
October 20, 2020
Researchers at the University of Cincinnati have identified new clues into ways tobacco use impacts patients with kidney cancer.
October 20, 2020
Researchers at the University of Cincinnati have identified new clues into ways tobacco use impacts patients with kidney cancer.
October 13, 2020
When Dr. Beth Shaughnessy, a UC professor and UC Health cancer surgeon, found out that she had cancer, she used it as an opportunity to share her path towards recovery and shed some light for others who might find themselves in the same situation.
September 30, 2020
Drug Target Review discusses findings of a study looking at the use of a naturally occurring lipid to prevent COVID-19 infection.
November 20, 2020
UC researchers treated their first study patient this week using a new cancer therapy that takes less than one second. This clinical trial is being hosted at the Cincinnati Children's/UC Health Proton Therapy Center.
November 24, 2020
University of Cincinnati researchers have discovered new clues into why some people with head and neck cancer respond to immunotherapy, while others don’t.
April 5, 2022
The University of Cincinnati's Shimul Shah, MD, was featured in a MedPage Today article highlighting recent research on the success of living donor transplants for patients with unresectable colorectal cancer liver metastases.
April 18, 2022
Yahoo! News featured University of Cincinnati research into the use of Optune devices that provide electrical field treatment to the brain as a treatment for glioblastomas.
January 27, 2022
WVXU highlighted the work of University of Cincinnati professor Dr. Kate Chard at the Cincinnati VA, which involves cutting edge research and evidence-based treatments for veterans with post-traumatic stress disorder.
September 2, 2021
Trisha Wise-Draper, MD, medical director of the UC Cancer Center's Clinical Trial Office and associate professor of medicine in the Division of Hematology/Oncology, spoke with Local 12's Liz Bonis about the latest research leading to the recommendation that cancer patients should receive a third dose of mRNA COVID-19 vaccines.
October 25, 2021
The University of Cincinnati's Dr. Xiaoting Zhang has been awarded a patent for a novel RNA nanoparticle treatment for breast cancer.